Causes and Determinants of Mortality in HIV-Infected Adults With Tuberculosis: An Analysis From the CAMELIA ANRS 1295-CIPRA KH001 Randomized Trial | Zendy

Olivier Marcy | Zendy; Didier Laureillard | Zendy; Yoann Madec | Zendy; Sarin Chan | Zendy; Charles Mayaud | Zendy; Laurence Borand | Zendy; Narom Prak | Zendy; Chindamony Kim | Zendy; Kim Khemarin Lak | Zendy; Chanroeurn Hak | Zendy; Bunnet Dim | Zendy; Sok Thim | Zendy; JeanFrançois Delfraissy | Zendy; Anne E. Goldfeld | Zendy; F.–X. Blanc | Zendy

Open Access

Causes and Determinants of Mortality in HIV-Infected Adults With Tuberculosis: An Analysis From the CAMELIA ANRS 1295-CIPRA KH001 Randomized Trial

Author(s) -

Olivier Marcy,

Didier Laureillard,

Yoann Madec,

Sarin Chan,

Charles Mayaud,

Laurence Borand,

Narom Prak,

Chindamony Kim,

Kim Khemarin Lak,

Chanroeurn Hak,

Bunnet Dim,

Sok Thim,

JeanFrançois Delfraissy,

Anne E. Goldfeld,

F.–X. Blanc

Publication year - 2014

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciu283

Subject(s) - tuberculosis , medicine , mortality rate , cause of death , disease , pediatrics , immunology , pathology

Shortening the interval between antituberculosis treatment onset and initiation of antiretroviral therapy (ART) reduces mortality in severely immunocompromised human immunodeficiency virus (HIV)-infected patients with tuberculosis. A better understanding of causes and determinants of death may lead to new strategies to further enhance survival.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research